It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Characterizing the circulation of Mayaro virus (MAYV), an emerging arbovirus threat, is essential for risk assessment but challenging due to cross-reactivity with other alphaviruses such as chikungunya virus (CHIKV). Here, we develop an analytical framework to jointly assess MAYV epidemiology and the extent of cross-reactivity with CHIKV from serological data collected throughout French Guiana (N = 2697). We find strong evidence of an important sylvatic cycle for MAYV with most infections occurring near the natural reservoir in rural areas and in individuals more likely to go to the forest (i.e., adult males) and with seroprevalences of up to 18% in some areas. These findings highlight the need to strengthen MAYV surveillance in the region and showcase how modeling can improve interpretation of cross-reacting assays.
Mayaro virus (MAYV) is an emerging arbovirus, but cross-reactivity with other alphaviruses makes analysis of its epidemiology difficult. Here, the authors develop an analytical framework to assess MAYV epidemiology and find evidence for an important sylvatic cycle and seroprevalences of up to 18% in some areas of French Guiana.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Institut Pasteur, UMR2000, CNRS, Mathematical Modelling of Infectious Diseases Unit, Paris, France (GRID:grid.428999.7) (ISNI:0000 0001 2353 6535)
2 Institut Pasteur, UMR2000, CNRS, Mathematical Modelling of Infectious Diseases Unit, Paris, France (GRID:grid.428999.7) (ISNI:0000 0001 2353 6535); University of Cambridge, Department of Genetics, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
3 Institut Pasteur in French Guiana, Arbovirus National Reference Center, Cayenne, French Guiana (GRID:grid.5335.0)
4 Institut Pasteur in French Guiana, Epidemiology Unit, Cayenne, French Guiana (GRID:grid.5335.0)
5 Institut Pasteur, Environment and Infectious Risks Unit, Paris, France (GRID:grid.428999.7) (ISNI:0000 0001 2353 6535)
6 Institut Pasteur in French Guiana, Epidemiology Unit, Cayenne, French Guiana (GRID:grid.428999.7)
7 Institut Pasteur in French Guiana, Arbovirus National Reference Center, Cayenne, French Guiana (GRID:grid.428999.7)